AstraZeneca ends Calquence trial early after Phase 3 success in chronic lymphocytic leukaemia httpbit.ly2H5EmHk pharmapic.twitter.comQpTeuZzKKZ

AstraZeneca ends Calquence trial early after Phase 3 success in chronic lymphocytic leukaemia http://bit.ly/2H5EmHk  #pharmapic.twitter.com/QpTeuZzKKZ

13:45 EDT 8 May 2019 | Pharmafile

AstraZeneca ends Calquence trial early after Phase 3 success in chronic lymphocytic leukaemia http://bit.ly/2H5EmHk  #pharma pic.twitter.com/QpTeuZzKKZ

More From BioPortfolio on "AstraZeneca ends Calquence trial early after Phase 3 success in chronic lymphocytic leukaemia http://bit.ly/2H5EmHk  #pharmapic.twitter.com/QpTeuZzKKZ"